mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.2 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.3 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.3 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.3 |